Your web browser does not support JavaScript, but it does not affect browsing through the rest of the web site. Go to Main Content

Biomedical Technologies

Development Platform Technology for Botanical and Plant-Derived Drugs
ITRI provides manufacturers with complete services, ranging from the production, management, and control of medicinal materials to relevant certifications and applications in order to compensate for the lack of technologies in the industry. It has also strengthened Taiwan’s R&D capabilities in the pharmaceutical industry to expedite the process of launching domestically developed drug products to the market.
High Yield Breeding Technology for Photosynthetic Microalgae
Microalgae can effectively use light and CO2 to produce biomass. In addition to their applications in the food, feed, cosmetics, and pharmaceuticals industries, microalgae are also recognized as promising feedstocks for the production of biofuels and chemicals. ITRI has developed active substances and biomimetic compounds to promote the growth of microalgae.
Novel Lymphatic Delivery System for Cancer Metastasis
Metastasis occurs mainly via the lymphatic system. To treat late-stage cancer that has spread to lymph nodes, ITRI has developed the Novel Lymphatic Delivery System for Cancer Metastasis.
To develop Taiwan’s own cell therapy core technology in synchrony with global trends, ITRI invests in R&D on allogeneic mesenchymal stem cell (MSC) based therapeutic technologies and products.
Soft Material Additive Manufacturing Technology
ITRI’s Soft Material Additive Manufacturing Technology uses a guided and adjustable temperature nozzle design to solve the problem of blocked nozzles caused by soft materials (such as Thermoplastic Polyurethane, TPU).
GMP Production Platform of Botanical New Drugs for Clinical/
ITRI’s GMP–certified pilot plant for botanical drugs and quality analysis laboratory were built to support domestic producers in botanical medicine development.
High Potency MSC Serum–Free Medium (SF1)
ITRI developed a high potency MSC serum–free medium that can be used in cell therapies to close the technology gap.
Portable Intelligent Rapid Molecular Diagnostic System
Differing from traditional systems using large heating modules, ITRI’s miniaturized portable molecular diagnostic system adopts an innovative design for mechanisms and temperature control to enable polymerase chain reactions.
Innovative Regulation Technology for Microalgae Growth
Microalgae culturing has great potential in carbon capture and sequestration (CCS). With a fixation capacity of 1.8-2 kilograms of carbon per kilogram, microalgae are a good source for biofuel, along with a handful of high-value substances, such as astaxanthin.
Novel Collagen Scaffold–Based Biologics (Collabody)
Collabody™, a recombinant collagen peptide-scaffold and antibody fragment fusion technology developed by ITRI, embodies a special composite triplex structure that has three target-binding sites, in comparison with the two target-binding sites of the Y-shaped structure of conventional monoclonal antibodies.